Fig. 3 | Scientific Reports

Fig. 3

From: Mechanism of action for Troxerutin targeting the sialylation-related gene EGLN3 for the treatment of LUAD

Fig. 3

Functional explorations in sialylation-related subgroups. GSEA analyses were performed to identify Hallmarks (A), KEGG pathways (B) and Reactome pathways (C) enriched in the sialylation-related subgroups. (D) The abundances of 23 immune cells were compared between sialylation-related subgroups. (E) Differences in immune, stromal, and estimate scores between sialylation-related subgroups. *P < 0.05, **P < 0.01, ***P < 0.001, nsP > 0.05.

Back to article page